Skip to main content

Why WHO is delaying the approval for Covaxin?

Covaxin is India’s first indigenous vaccine against Covid-19 infection, was touted to play an important role in the country’s massive vaccination program. World Health Organization (WHO) has still not approved the vaccine for global use and seeks more data for final assessment likely on November 03rd. Why Hyderabad-based firm Bharat Biotech is facing reluctance from W.H.O.? India is the only nation after China to complete 1 billion doses of coronavirus vaccines. Both Covishield and Covaxin have played vital roles in administrating the vaccine jabs in the country. Currently, India has three vaccines like Covishield, Covaxin, and Sputnik V. So far, WHO gave approval for seven vaccines like Moderna, Pfizer, AstraZeneca, Covishield, J&J, Sinopharm, and Sinovac for the use of emergency approval in the world.


India’s home-grown vaccine Covaxin is definitely missed from the WHO list. Why companies are seeking WHO approval. If WHO gave approval for any vaccine it is nothing but global recognition most countries follow. WHO is still hasn’t approved Covaxin which seems to be a big concern for Indians. People who administered Covaxin can’t travel abroad and take multiple covid-19 tests and quarantine in some countries. The UK refused to recognize Cowin certificates, India made quarantine mandatory for UK citizens. Students want to go abroad for studies and employees working in MNCs are supposed to travel as per the requirement but they can’t due to delay in WHO approval. 9 nations other than India and two EU nations (Estonia and Greece) are using Covaxin.


But WHO is dragging in giving approval for Indian Covaxin since April 2021. Bharat Biotech predicted on July 09th that WHO gave approval within six weeks. As of now, it is 15 weeks completed, and WHO delaying the approval. Pfizer got approval within 6 weeks and Moderna within 9 weeks, WHO has not come to a conclusion on Covaxin. Millions of Indians are stuck in limbo. There is a lot of ambiguity in this approval process. There is a number of issues had surfaced when the approval was given to the vaccine by the Indian regulator and cannot be ignored. Is there any pressure to delay the approval of Covaxin? The delay in grant of approval for it WHO is a result of China’s control over the WHO.

Comments

Popular posts from this blog

Photo : Savitri during her last days

Even after 4 decades of her death, people are very much interested to watched her (Savitri) biopic. Mahanati turned to be stupendous success. On eve of remembering Savitri, here we posted Savitri photo. The photo seems her last days. The man stand behind Savitri is Gemini Ganeshan who married Savitri. It seems that she suffered bad days during her last days.

Difference between DELETE and TRUNCATE

This is the common interview question for every SQL Developer and DBA position. DELETE TRUNCATE DML (Data Manipulation Language) Command. DDL (Data Definition Language) Command. It can be rollback. It can't be rollback. Using DELETE we can remove some or all records from the table. We can use WHERE clause with it. Using TRUNCATE we can remove all records from the table at once. We can't use WHERE clause with it. DELETE command is slow in performance. TRUNCATE command is super faster in performance. All deleted Triggers fire on DELETE command. No Trigger can be fired on TRUNCATE command. DELETE can't reset high water mark. TRUNCATE can reset high water mark. DELETE can't release the space from the table. TRUNCATE can release the space from the table.

Producers demand 18 crores for Ceded for Pavan and Trivikram film

Director Rajamouli showed the path to all other producers on how to sell product (movie) in different ways across the word. Telugu Cinema has vertically divided in two ways Before and after Bahubali. Bahubali proves that there were no boundaries in selling the movie. Other producers who are doing with star heros like Pavan, Mahesh and Jr. NTR will follow Rajamouli in this regard. But there is slight difference with Bahubali and other heros films. Unfortunately, producers and distributors fail to notice the gap. Bahubali is universal movie which was apt to all sections in the world. That is the reason for getting huge collections across the world. We didn't expect the same situation for Prabas's next movie even though his popularity increased with Bahubali. Radha Krishna who produced movies like Julayi and A. AA.. will plan to produce next film with Pavan and Trivikram. Movie was not yet started but distributors rushed toward producer for getting area-wise rights.Obviously, ...